Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease

Elisabeth R. Van Wering; Birgit E. M. Van der Linden-Schrever; Tomasz Szczepański; Marja J. Willemse; Ed A. Baars; Hanne M. Van Wijngaarde-Schmitz; Willem A. Kamps; Jacques J. M. Van Dongen

doi:10.1046/j.1365-2141.2000.02143.x

Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease

British Journal of Haematology ◽

10.1046/j.1365-2141.2000.02143.x ◽

2000 ◽

Vol 110 (1) ◽

pp. 139-146 ◽

Cited By ~ 72

Author(s):

Elisabeth R. Van Wering ◽

Birgit E. M. Van der Linden-Schrever ◽

Tomasz Szczepański ◽

Marja J. Willemse ◽

Ed A. Baars ◽

...

Keyword(s):

Acute Lymphoblastic Leukaemia ◽

B Cell ◽

Minimal Residual Disease ◽

Lymphoblastic Leukaemia ◽

Residual Disease ◽

B Cell Precursors ◽

Minimal Residual

Download Full-text

Detailed immunophenotyping of B-cell precursors in regenerating bone marrow of acute lymphoblastic leukaemia patients: implications for minimal residual disease detection

British Journal of Haematology ◽

10.1111/bjh.14682 ◽

2017 ◽

Vol 178 (2) ◽

pp. 257-266 ◽

Cited By ~ 10

Author(s):

Prisca M. J. Theunissen ◽

Lukasz Sedek ◽

Valerie De Haas ◽

Tomasz Szczepanski ◽

Alita Van Der Sluijs ◽

...

Keyword(s):

Bone Marrow ◽

Acute Lymphoblastic Leukaemia ◽

B Cell ◽

Minimal Residual Disease ◽

Lymphoblastic Leukaemia ◽

Residual Disease ◽

Disease Detection ◽

Minimal Residual Disease Detection ◽

B Cell Precursors ◽

Minimal Residual

Download Full-text

Satisfactory outcome after intensive chemotherapy with pragmatic use of minimal residual disease (MRD) monitoring in older patients with Philadelphia-negative B cell precursor acute lymphoblastic leukaemia: a Swedish registry-based study

Medical Oncology ◽

10.1007/s12032-015-0582-2 ◽

2015 ◽

Vol 32 (4) ◽

Author(s):

Emma Bergfelt ◽

Piotr Kozlowski ◽

Lucia Ahlberg ◽

Erik Hulegårdh ◽

Hans Hägglund ◽

...

Keyword(s):

Acute Lymphoblastic Leukaemia ◽

B Cell ◽

Minimal Residual Disease ◽

Lymphoblastic Leukaemia ◽

Older Patients ◽

Residual Disease ◽

Intensive Chemotherapy ◽

Cell Precursor ◽

Satisfactory Outcome ◽

Minimal Residual

Download Full-text

Blinatumomab vs historic standard‐of‐care treatment for minimal residual disease in adults with B‐cell precursor acute lymphoblastic leukaemia

European Journal Of Haematology ◽

10.1111/ejh.13575 ◽

2021 ◽

Keyword(s):

Acute Lymphoblastic Leukaemia ◽

B Cell ◽

Minimal Residual Disease ◽

Lymphoblastic Leukaemia ◽

Residual Disease ◽

Standard Of Care ◽

Cell Precursor ◽

Care Treatment ◽

Standard Of Care Treatment ◽

Minimal Residual

Download Full-text

Flow cytometric minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukaemia patients treated with CD19‐targeted therapies — a EuroFlow study

British Journal of Haematology ◽

10.1111/bjh.17992 ◽

2021 ◽

Author(s):

Martijn W. C. Verbeek ◽

Chiara Buracchi ◽

Anna Laqua ◽

Stefan Nierkens ◽

Lukasz Sedek ◽

...

Keyword(s):

Acute Lymphoblastic Leukaemia ◽

B Cell ◽

Minimal Residual Disease ◽

Targeted Therapies ◽

Lymphoblastic Leukaemia ◽

Residual Disease ◽

Disease Assessment ◽

Cell Precursor ◽

Flow Cytometric ◽

Minimal Residual

Download Full-text

Comments on the article ‘Donor-derived CD19-targeted T cell infusion induces minimal residual disease-negative remission in relapsed B-cell acute lymphoblastic leukaemia with no response to donor lymphocyte infusions after haploidentical haematopoietic st

British Journal of Haematology ◽

10.1111/bjh.15199 ◽

2018 ◽

Vol 184 (5) ◽

pp. 881-882

Author(s):

Tingting Pan ◽

Jiaqian Qi ◽

Yuejun Liu ◽

Depei Wu ◽

Yue Han

Keyword(s):

T Cell ◽

Acute Lymphoblastic Leukaemia ◽

B Cell ◽

Minimal Residual Disease ◽

Lymphoblastic Leukaemia ◽

Residual Disease ◽

Minimal Residual ◽

Donor Lymphocyte Infusions

Download Full-text

Comments on the article: ‘Donor-derived CD19-targeted T cell infusion induces minimal residual disease-negative remission in relapsed B-cell acute lymphoblastic leukaemia with no response to donor lymphocyte infusions after haploidentical haematopoietic s

British Journal of Haematology ◽

10.1111/bjh.15193 ◽

2018 ◽

Vol 184 (5) ◽

pp. 882-883

Author(s):

Yifei Cheng ◽

Yuhong Chen ◽

Chenhua Yan ◽

Yu Wang ◽

Yao Chen ◽

...

Keyword(s):

T Cell ◽

Acute Lymphoblastic Leukaemia ◽

B Cell ◽

Minimal Residual Disease ◽

Lymphoblastic Leukaemia ◽

Residual Disease ◽

Minimal Residual ◽

Donor Lymphocyte Infusions

Download Full-text

Simplified strategies for minimal residual disease detection in B‐cell precursor acute lymphoblastic leukaemia

British Journal of Haematology ◽

10.1046/j.1365-2141.1996.d01-1917.x ◽

1996 ◽

Vol 95 (2) ◽

pp. 281-290 ◽

Cited By ~ 23

Author(s):

J. Landman‐Parker ◽

J. Aubin ◽

E. Delabesse ◽

M‐D. Tabone ◽

M. Adam ◽

...

Keyword(s):

Acute Lymphoblastic Leukaemia ◽

B Cell ◽

Minimal Residual Disease ◽

Lymphoblastic Leukaemia ◽

Residual Disease ◽

Disease Detection ◽

Cell Precursor ◽

Minimal Residual Disease Detection ◽

Minimal Residual

Download Full-text

Blinatumomab vs historic standard‐of‐care treatment for minimal residual disease in adults with B‐cell precursor acute lymphoblastic leukaemia

European Journal Of Haematology ◽

10.1111/ejh.13375 ◽

2020 ◽

Vol 104 (4) ◽

pp. 299-309 ◽

Cited By ~ 3

Author(s):

Nicola Gökbuget ◽

Hervé Dombret ◽

Sebastian Giebel ◽

Monika Brüggemann ◽

Michael Doubek ◽

...

Keyword(s):

Acute Lymphoblastic Leukaemia ◽

B Cell ◽

Minimal Residual Disease ◽

Lymphoblastic Leukaemia ◽

Residual Disease ◽

Standard Of Care ◽

Cell Precursor ◽

Care Treatment ◽

Standard Of Care Treatment ◽

Minimal Residual

Download Full-text

Clinical utility of next-generation sequencing-based minimal residual disease in paediatric B-cell acute lymphoblastic leukaemia

British Journal of Haematology ◽

10.1111/bjh.14420 ◽

2016 ◽

Vol 176 (2) ◽

pp. 248-257 ◽

Cited By ~ 15

Author(s):

Yuko Sekiya ◽

Yinyan Xu ◽

Hideki Muramatsu ◽

Yusuke Okuno ◽

Atsushi Narita ◽

...

Keyword(s):

Next Generation Sequencing ◽

Acute Lymphoblastic Leukaemia ◽

B Cell ◽

Minimal Residual Disease ◽

Lymphoblastic Leukaemia ◽

Clinical Utility ◽

Residual Disease ◽

Next Generation ◽

Generation Sequencing ◽

Minimal Residual

Download Full-text

Faculty Opinions recommendation of Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725402243.793506131 ◽

2015 ◽

Author(s):

Jan Starý ◽

Michaela Kotrová

Keyword(s):

Acute Lymphoblastic Leukaemia ◽

Prospective Study ◽

Minimal Residual Disease ◽

Lymphoblastic Leukaemia ◽

Clinical Utility ◽

Residual Disease ◽

Childhood Acute Lymphoblastic Leukaemia ◽

A Prospective Study ◽

Minimal Residual

Download Full-text